Analyst Ratings for Bausch Health Companies (BHC) [Neutrals]
BHC Rating Summary
BHC Price Target Summary
- Highest: $35.00 (Cowen)
- Lowest: $6.00 (Piper Sandler)
- Average: $13.43
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$13.43 (+70.8%)
* Over Last 12-Mos
Rating Score: 5.4 / 10
Percentile Rank: 57%
Avg. $ Target:
$13.43 (+70.8%)
* Over Last 12-Mos
Rating Score: 5.4 / 10
Percentile Rank: 57%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/29/2022 | RBC Capital » Updated 9/1/2022 |
Doug Miehm | Downgrade | Sector Perform (Outperform) |
8.00 (4.50) |
5.10 (7.86) |
54.12% | Details |
| 7/29/2022 | Truist Securities | Gregory Fraser | Downgrade | Hold (Buy) |
N/A (N/A) |
8.68 (7.86) |
-9.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
